Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1996 | 1 |
2001 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors.
J Immunother Cancer. 2022 Aug;10(8):e005147. doi: 10.1136/jitc-2022-005147.
J Immunother Cancer. 2022.
PMID: 35940825
Free PMC article.
Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies.
Ansell SM, Flinn I, Taylor MH, Sikic BI, Brody J, Nemunaitis J, Feldman A, Hawthorne TR, Rawls T, Keler T, Yellin MJ.
Ansell SM, et al. Among authors: rawls t.
Blood Adv. 2020 May 12;4(9):1917-1926. doi: 10.1182/bloodadvances.2019001079.
Blood Adv. 2020.
PMID: 32380537
Free PMC article.
Clinical Trial.
Item in Clipboard
N100 evoked potential latency variation and startle in schizophrenia.
Young KA, Smith M, Rawls T, Elliott DB, Russell IS, Hicks PB.
Young KA, et al. Among authors: rawls t.
Neuroreport. 2001 Mar 26;12(4):767-73. doi: 10.1097/00001756-200103260-00031.
Neuroreport. 2001.
PMID: 11277581
Item in Clipboard
This doctor ignored his Yale professors. He's glad he did.
Rawls T.
Rawls T.
Med Econ. 1996 Jun 24;73(12):168-72.
Med Econ. 1996.
PMID: 10158312
No abstract available.
Item in Clipboard
Cite
Cite